Investigating GLP-1 RAs reveals their impact on women's health, addressing metabolic disorders, reproductive health, and ...

“The launch of our GLP-1 weight management solution is the latest ... high blood pressure, anxiety, and depression with evidence-based treatment. Vida’s team of obesity medicine-certified ...

The PRAC still has another safety review on the go for the GLP-1 class, however ... taking them for signs of emerging or worsening depression. The labels for diabetes therapies Ozempic and ...

I n addition to their origins as treatment for type 2 diabetes, GLP-1 receptor agonists like Ozempic and Wegovy are often ...

The company, launched with help from ex-Novartis executives, is targeting glutamate signaling in the brain to help treat ...

Tom Nolan reviews this week’s research Is it time to treat male partners of women with bacterial vaginosis? A trial in the New England Journal of Medicine recruited women with confirmed bacterial ...

People with a higher sense of purpose experience a 46% lower mortality risk and are 33% less likely to develop sleep problems.

BRENTWOOD, Tenn., March 20, 2025 /PRNewswire/ -- Currax Pharmaceuticals LLC ("Currax"), a specialty Pharmaceutical company and manufacturer of the #1 branded ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss.